Japan's yen for regenerative meds: Fujifilm to buy Cellular Dynamics
Fujifilm will buy Cellular Dynamics International (CDI) for $307m to add induced stem cells to its offering and further build in regenerative medicines.
Fujifilm will buy Cellular Dynamics International (CDI) for $307m to add induced stem cells to its offering and further build in regenerative medicines.
Worthing Biochemical has launched a range of animal product-free bioprocessing enzymes citing demand for products with no risk of TSE contamination.
Cobra Biologics and Tecrea will work together on scaling up Adeno Associated Virus (AAV) production.
GSK expects to begin supplying the UK with meningitis B vaccine Bexsero later this year after reaching an agreement on price.